ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹3.23 Cr |
Mar2022 | ₹3.23 Cr |
Mar2021 | ₹3.23 Cr |
Mar2020 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹3.23 Cr | 0.00 | |
Mar2022 | ₹3.23 Cr | 0.00 | |
Mar2021 | ₹3.23 Cr | 0.00 | |
Mar2020 | ₹3.23 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹4,240.3 Cr | -9.3% | -35.9% | -18.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,213.0 Cr | 3.9% | -3.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,403.0 Cr | 1.8% | -4.5% | 53.9% | Stock Analytics | |
CIPLA | ₹117,415.0 Cr | -0.6% | -0.3% | -2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,791.0 Cr | 1.2% | -3% | 14.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,228.2 Cr | -3% | -9.5% | -11.7% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -9.3% |
-35.9% |
-18.2% |
SENSEX | 0.4% |
-4.9% |
-0.1% |
You may also like the below Video Courses